| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d71f4d06c9a84c3b0d6f69d842a84175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a25729437bb759a0e8c52360ecbe5eee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68d80933a35bd9437a0da03fd5bfb590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4913776ffabab8861f9175157fe378a8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-03005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2019-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0839657d64091d4094d61f41be23e88f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c854612b7d529b3747b1e916bf89789f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b48bb213cf0e662f45081ab3d875c475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c022acd56edf24246ad9b284f4b1142d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe7286b2caff5454d106249a8ac15a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0175bfecbfe6597ae71e953e5362f550
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68bab5004cf9ce3939f43a617ffa1591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_283fbbe98f7d3706b2b9ef82db530ad0 |
| publicationDate |
2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019144209-A1 |
| titleOfInvention |
Nanometric pharmaceutical composition for release of interfering rna molecules and use thereof |
| abstract |
The present invention relates to a nanometric-scale composition in the form of liposomes or nanoemulsions containing strands of interfering RNA (siRNA) capable of silencing the gene responsible for the expression of superexposed adhesion proteins in tumours, such as the enzyme ecto-5'-nucleotidase/CD73 (CD73) which is superexpressed in multiform glioblastoma and in other types of tumour. The binding of the liposomes or nanoemulsions to the siRNA promotes a site-directed release complex capable of being incorporated into various types of formulation, such as an intratumoral or intravenous injection or nasal administration. |
| priorityDate |
2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |